DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 12-Month Low – Here’s What Happened

DENTSPLY SIRONA Inc. (NASDAQ:XRAY)’s stock price reached a new 52-week low during mid-day trading on Thursday. The company traded as low as $8.77 and last traded at $8.7250, with a volume of 145462 shares changing hands. The stock had previously closed at $8.86.

Analyst Ratings Changes

A number of research firms have weighed in on XRAY. Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Monday, August 3rd. Barclays raised their price target on DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research report on Monday, August 24th. BMO Capital Markets dropped their price objective on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research note on Thursday, September 17th. Barrington Research set a $15.00 price objective on DENTSPLY SIRONA in a research report on Monday, August 10th. Finally, Piper Sandler increased their target price on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Three analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $13.31.

DENTSPLY SIRONA Trading Down 2.5%

The stock has a market capitalization of $1.72 billion, a price-to-earnings ratio of -3.14, a PEG ratio of 1.14 and a beta of 0.84. The company’s 50 day moving average is $11.27 and its 200 day moving average is $11.28. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. During the same period in the prior year, the firm earned $0.52 EPS. The business’s revenue was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, research analysts forecast that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently added to or reduced their stakes in XRAY. BlackRock Inc. acquired a new position in DENTSPLY SIRONA in the 2nd quarter valued at approximately $283,405,000. Southpoint Capital Advisors LP bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $116,000,000. Armistice Capital LLC grew its holdings in shares of DENTSPLY SIRONA by 27.2% during the 4th quarter. Armistice Capital LLC now owns 7,298,000 shares of the medical instruments supplier’s stock worth $83,416,000 after purchasing an additional 1,562,000 shares in the last quarter. Invenomic Capital Management LP increased its position in shares of DENTSPLY SIRONA by 17.9% during the fourth quarter. Invenomic Capital Management LP now owns 5,132,036 shares of the medical instruments supplier’s stock valued at $58,659,000 after purchasing an additional 780,837 shares during the period. Finally, Edmond DE Rothschild Holding S.A. bought a new stake in shares of DENTSPLY SIRONA during the second quarter valued at approximately $47,780,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.